home / stock / kne:cc / kne:cc news

KNE:CC News and Press, Kane Biotech Inc. From 09/02/23

Stock Information
Company Name: Kane Biotech Inc.
Stock Symbol: KNE:CC
Market: TSXVC
Website: kanebiotech.com
Menu
KNE:CC KNE:CC Quote KNE:CC Short KNE:CC News KNE:CC Articles KNE:CC Message Board
Get KNE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
KNE:CC - Kane Biotech: Top 10 Undervalued Biotechnology Industry Stocks (KNE)

2023-09-02 20:00:00 ET Kane Biotech is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to det...
KNE:CC - Kane Biotech Announces Second Quarter 2023 Financial Results

68% Increase in Product and Services Revenue; 74% Increase in Royalties Revenue WINNIPEG, Manitoba, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2023 financial...

KNE:CC - Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 - Conference Call to Follow

WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove ...

KNE:CC - Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) today a...
KNE:CC - Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health

WINNIPEG, Manitoba, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) announced today that it has engaged Research Capital Corporation as Kane’s exclusive financi...

KNE:CC - Kane Biotech Announces Issuance of Restricted Share Units

WINNIPEG, Manitoba, June 23, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 9,703,809 restricted share units of the Company (“RSUs”) to various directors, officers...

KNE:CC - Kane Biotech Announces First Quarter 2023 Financial Results

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove m...
KNE:CC - Kane Biotech Announces FDA 510(k) Clearance for its coactiv+(TM) Antimicrobial Wound Gel

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that on May 24, 2023 it received 510(k) clearance of its coactiv+ ™ Antimicrobial Wound Gel from the U.S. Food and Drug...

KNE:CC - Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 - Conference Call to Follow

WINNIPEG, Manitoba, May 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove m...

KNE:CC - Kane Biotech Announces Fourth Quarter and Full Year 2022 Financial Results

WINNIPEG, Manitoba, April 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced its fourth quarter and full year 2022 financial results. Fourth Quarter Financial Highlights Total reve...
Previous 10 Next 10